Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Tharimmune logo

Tharimmune

Recent Financing

Equity

Recent Raise

$540M

Tharimmune is a clinical-stage biotechnology company that is branching into digital assets by acquiring Canton Coin and operating as a Super Validator on the Canton Network blockchain.

Cheshire, United Kingdom
11-50
Publicly Traded
tharimmune.com
PitchBook

Highlights

Focus Areas

Biopharma
Biotechnology
Clinical Trials

Recent Investors

ARK Invest logo
SBI Group logo
F
Tradeweb Markets logo
Bitwave logo
Clear Street logo
Broadridge Financial Solutions logo
Digital Asset logo
Liberty City Ventures logo
DRW Venture Capital logo
Copper logo
Polychain Capital logo

Financials

$540M

Total Raised

1

Funding round

12

Investors


Team

Upgrade to view the team

See the team members at Tharimmune.